Med Hypothes 129:109245 Rai SN, Chaturvedi VK, Singh P, Singh BK, Singh M (2020) Mucuna pruriens in Parkinsons and in some other diseases: recent advancement and future prospective
Subcutaneous semaglutide (0.5 mg and 1.0 mg) and oral semaglutide (7 mg and 14 mg) led to significant weight reductions compared to placebo
Insurance & cost GLP-1 coverage depends heavily on the medication, the indication, and your specific plan
Common musculoskeletal side effects may include muscle weakness, pain, or stiffness
Key cardiovascular and metabolic conditions include: Hypertension particularly nocturnal hypotension or poorly controlled blood pressure Diabetes mellitus both type 1 and type 2, with microvascular complications Hyperlipidemia contributing to atherosclerotic vascular disease Obstructive sleep apnea causing intermittent hypoxia and hemodynamic fluctuations Coronary artery disease reflecting systemic atherosclerosis Smoking promoting endothelial dysfunction and vascular disease Age represents an independent risk factor, with NAION incidence increasing significantly after 50 years